MOSAIC is a five-year global project to accelerate introduction and scale-up of new biomedical prevention products and expedite their availability, acceptance, uptake, and impact in PEPFAR programs to help individuals, especially women, prevent HIV and other infectious diseases.
The world is closer than ever to ending HIV as a public health threat. As the global response to the HIV epidemic continues to transition from an emergency response to one focused on sustaining the progress we’ve made, it is critical that we continue to find innovative solutions to address new challenges.
Continue Reading
Emerging products provide more options and the potential for individuals to find the HIV prevention methods that best suit their needs and preferences. But what does PrEP choice look like, and how can it be protected for all individuals who could benefit from HIV prevention? This blog post presents the choice principles, offers illustrative examples of each principle, and outlines what could come next to advance choice in HIV prevention efforts.
Continue Reading
Expanding access to and uptake of PrEP products among young people, especially adolescent girls and young women, will be key to ending the HIV epidemic. But how do we ensure HIV prevention efforts resonate with and are effective for young millennials and Gen Z? What does meaningful youth engagement in PrEP delivery really mean?
Continue Reading
What sets CATALYST apart is the study’s emphasis on meaningful involvement of young people at every stage of the research to understand end-user perspectives and help tailor the study to meet their needs. This makes us hopeful because the inclusion of young people in the CATALYST journey has not been tokenistic; rather our contributions have been reflected in the whole process so far. In this post, we describe three ways youth have been engaged in CATALYST.
Continue Reading
This IAS 2023 session will review evidence from recent studies designed to inform CAB PrEP introduction in Asia; identify regional priorities for a CAB implementation science agenda; examine regional lessons from oral PrEP introduction and scale-up; highlight progress and lessons from preparing for CAB rollout in Africa; and introduce available policy and program planning tools and resources to help countries prepare for CAB rollout.
Continue Reading
As marketing for PrEP has evolved, we have seen a shift away from strategies we know don’t work: fear-based, stigma-reinforcing, HIV-centric, medicalized, and far-future focused. Yet we need to go a step further and analyze all the insights that form the backbone of our campaigns and our messages through a gender-transformative lens.
Continue Reading
We are excited to announce the launch of Catalyzing Access to New Prevention Products to Stop HIV (CATALYST), MOSAIC’s flagship product introduction study. CATALYST will provide and assess an enhanced service delivery package that includes oral PrEP, the PrEP ring, and injectable cabotegravir for PrEP.
Continue Reading
In this podcast episode, NextGen Squad members answer important questions, noting which youth-led activities USAID should invest in and how HIV programs can better involve youth and youth-led organizations in their work. They also discuss the importance of evaluating impact and share thoughts on utilizing social media to reach young people with key messages about HIV prevention.
Continue Reading
Demand for oral PrEP has been an issue. How can we do marketing differently with a multi-product PrEP portfolio? What do we want young women’s hearts to feel—and minds to think—about PrEP? These question about the positioning of PrEP are central to its branding as a multi-product category.
Continue Reading
MOSAIC is heading to Durban, South Africa, for the 11th SA AIDS conference. This year’s conference theme: Act, connect, and end the epidemic. We invite conference attendees to join us for the following sessions.
Continue Reading